GB202015585D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB202015585D0
GB202015585D0 GBGB2015585.9A GB202015585A GB202015585D0 GB 202015585 D0 GB202015585 D0 GB 202015585D0 GB 202015585 A GB202015585 A GB 202015585A GB 202015585 D0 GB202015585 D0 GB 202015585D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2015585.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Betagenon Bio AB
Original Assignee
Betagenon Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betagenon Bio AB filed Critical Betagenon Bio AB
Priority to GBGB2015585.9A priority Critical patent/GB202015585D0/en
Publication of GB202015585D0 publication Critical patent/GB202015585D0/en
Priority to AU2021352146A priority patent/AU2021352146A1/en
Priority to MX2023003825A priority patent/MX2023003825A/es
Priority to EP21816508.2A priority patent/EP4222147B1/en
Priority to CA3193947A priority patent/CA3193947A1/en
Priority to HUE21816508A priority patent/HUE071685T2/hu
Priority to KR1020237014527A priority patent/KR20230079163A/ko
Priority to JP2023520459A priority patent/JP7793614B2/ja
Priority to CN202180067894.4A priority patent/CN116368141B/zh
Priority to PCT/GB2021/052535 priority patent/WO2022069894A1/en
Priority to PL21816508.2T priority patent/PL4222147T3/pl
Priority to US18/028,192 priority patent/US12643918B2/en
Priority to ES21816508T priority patent/ES3018732T3/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/65392—Five-membered rings containing two nitrogen atoms
    • C07F9/65397—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB2015585.9A 2020-10-01 2020-10-01 New compounds Ceased GB202015585D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB2015585.9A GB202015585D0 (en) 2020-10-01 2020-10-01 New compounds
ES21816508T ES3018732T3 (en) 2020-10-01 2021-09-30 Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders
KR1020237014527A KR20230079163A (ko) 2020-10-01 2021-09-30 티아다이아졸론 유도체와 당뇨병 및 관련 장애를 치료하기 위한 ampk 작용제로서 그 용도
MX2023003825A MX2023003825A (es) 2020-10-01 2021-09-30 Derivados de tiadiazolona y su uso como agonistas de ampk para el tratamiento de la diabetes y trastornos relacionados.
EP21816508.2A EP4222147B1 (en) 2020-10-01 2021-09-30 Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders
CA3193947A CA3193947A1 (en) 2020-10-01 2021-09-30 Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders
HUE21816508A HUE071685T2 (hu) 2020-10-01 2021-09-30 Tiadiazolon-származékok és alkalmazásuk AMPK agonistákként diabétesz és kapcsolódó rendellenességek kezelésében
AU2021352146A AU2021352146A1 (en) 2020-10-01 2021-09-30 Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders
JP2023520459A JP7793614B2 (ja) 2020-10-01 2021-09-30 チアジアゾロン誘導体と、それらの糖尿病および関連疾患の治療のためのampkアゴニストとしての使用
CN202180067894.4A CN116368141B (zh) 2020-10-01 2021-09-30 噻二唑酮衍生物及其作为ampk激动剂用于治疗糖尿病和相关疾病的用途
PCT/GB2021/052535 WO2022069894A1 (en) 2020-10-01 2021-09-30 Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders
PL21816508.2T PL4222147T3 (pl) 2020-10-01 2021-09-30 Pochodne tiadiazolonu i ich zastosowanie jako agonistów ampk w leczeniu cukrzycy i powiązanych z nią zaburzeń
US18/028,192 US12643918B2 (en) 2020-10-01 2021-09-30 Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2015585.9A GB202015585D0 (en) 2020-10-01 2020-10-01 New compounds

Publications (1)

Publication Number Publication Date
GB202015585D0 true GB202015585D0 (en) 2020-11-18

Family

ID=73223766

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2015585.9A Ceased GB202015585D0 (en) 2020-10-01 2020-10-01 New compounds

Country Status (13)

Country Link
US (1) US12643918B2 (cg-RX-API-DMAC7.html)
EP (1) EP4222147B1 (cg-RX-API-DMAC7.html)
JP (1) JP7793614B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230079163A (cg-RX-API-DMAC7.html)
CN (1) CN116368141B (cg-RX-API-DMAC7.html)
AU (1) AU2021352146A1 (cg-RX-API-DMAC7.html)
CA (1) CA3193947A1 (cg-RX-API-DMAC7.html)
ES (1) ES3018732T3 (cg-RX-API-DMAC7.html)
GB (1) GB202015585D0 (cg-RX-API-DMAC7.html)
HU (1) HUE071685T2 (cg-RX-API-DMAC7.html)
MX (1) MX2023003825A (cg-RX-API-DMAC7.html)
PL (1) PL4222147T3 (cg-RX-API-DMAC7.html)
WO (1) WO2022069894A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3075388T3 (en) 2019-10-18 2026-08-04 Betagenon Ab New formulations
GB202015585D0 (en) 2020-10-01 2020-11-18 Betagenon Bio Ab New compounds
GB202112529D0 (en) * 2021-09-02 2021-10-20 Betagenon Bio Ab New compounds
JPWO2024075784A1 (cg-RX-API-DMAC7.html) * 2022-10-05 2024-04-11

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010270030B2 (en) 2009-07-08 2015-12-24 Baltic Bio Ab 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer
WO2013108026A1 (en) 2012-01-17 2013-07-25 Baltic Bio Ab Thiadiazolone derivatives useful in the treatment of diabetes
WO2020095010A1 (en) * 2018-11-05 2020-05-14 Balticgruppen Bio Ab Methods of treating diabetes in severe insulin-resistant diabetic subjects
GB201915094D0 (en) 2019-10-18 2019-12-04 Balticgruppen Bio Ab New formulations
ES3075388T3 (en) 2019-10-18 2026-08-04 Betagenon Ab New formulations
GB202015585D0 (en) 2020-10-01 2020-11-18 Betagenon Bio Ab New compounds
GB202100352D0 (en) 2021-01-12 2021-02-24 Balticgruppen Bio Ab New methods
GB202112529D0 (en) 2021-09-02 2021-10-20 Betagenon Bio Ab New compounds
CN122421964A (zh) 2023-07-20 2026-07-17 塔吉农有限责任公司 使用双重ampk激活剂和线粒体解偶联剂调节血糖水平的方法
JP2026526085A (ja) 2023-07-20 2026-08-05 ベタゲノン アーベー 代謝非柔軟性により誘発される心筋症の治療方法
CN121925257A (zh) 2023-08-03 2026-04-24 塔吉农有限责任公司 用pdk抑制剂4-氯-n-(2-(4-氯苄基)-3-氧代-2,3-二氢-1,2,4-噻二唑-5-基)苯甲酰胺治疗癌症
WO2025252672A1 (en) 2024-06-03 2025-12-11 Betagenon Ab Use of tryptophan and metabolites thereof as biomarkers for treatment methods

Also Published As

Publication number Publication date
ES3018732T3 (en) 2025-05-19
MX2023003825A (es) 2023-06-06
PL4222147T3 (pl) 2025-06-09
EP4222147B1 (en) 2025-03-19
CN116368141A (zh) 2023-06-30
HUE071685T2 (hu) 2025-09-28
JP2023543924A (ja) 2023-10-18
CA3193947A1 (en) 2022-04-07
KR20230079163A (ko) 2023-06-05
AU2021352146A1 (en) 2023-06-01
US12643918B2 (en) 2026-06-02
WO2022069894A1 (en) 2022-04-07
JP7793614B2 (ja) 2026-01-05
EP4222147A1 (en) 2023-08-09
EP4222147C0 (en) 2025-03-19
US20230382930A1 (en) 2023-11-30
CN116368141B (zh) 2025-09-23

Similar Documents

Publication Publication Date Title
EP4452937A4 (en) CONNECTIONS
GB202013721D0 (en) New compounds
GB202112529D0 (en) New compounds
GB202104039D0 (en) New compounds
GB202001564D0 (en) Compounds
GB201912404D0 (en) New compounds
GB202104038D0 (en) New compounds
GB202104033D0 (en) New compounds
GB202113583D0 (en) New compounds
GB202109946D0 (en) New compounds
GB202107406D0 (en) New Compounds
GB202104040D0 (en) New compounds
GB202101614D0 (en) New compounds
GB202101600D0 (en) New compounds
GB202101607D0 (en) New compounds
GB202101609D0 (en) New compounds
GB202101621D0 (en) New compounds
GB202101620D0 (en) New compounds
GB202101616D0 (en) New compounds
GB202101617D0 (en) New compounds
GB202101602D0 (en) New compounds
GB202012871D0 (en) New compounds
GB202009083D0 (en) New compounds
GB202008158D0 (en) New compounds
GB202001869D0 (en) New compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)